Apogee Therapeutics Files 8-K: Operations & Financials
Ticker: APGE · Form: 8-K · Filed: Mar 3, 2025 · CIK: 1974640
| Field | Detail |
|---|---|
| Company | Apogee Therapeutics, Inc. (APGE) |
| Form Type | 8-K |
| Filed Date | Mar 3, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: operations, financials, disclosure
Related Tickers: APGE
TL;DR
APGE filed an 8-K on March 3rd covering operations and financials.
AI Summary
On March 3, 2025, Apogee Therapeutics, Inc. filed an 8-K report detailing its results of operations and financial condition. The filing also included Regulation FD disclosures and financial statements and exhibits. The company, incorporated in Delaware, is based in Waltham, MA.
Why It Matters
This 8-K filing provides crucial updates on Apogee Therapeutics' operational and financial status, which is essential for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of operational and financial information, not indicating any immediate or significant new risks.
Key Players & Entities
- Apogee Therapeutics, Inc. (company) — Registrant
- March 3, 2025 (date) — Date of earliest event reported
- Waltham, MA (location) — Principal Executive Offices
- 001-41740 (other) — Commission File Number
FAQ
What specific financial information is being disclosed in this 8-K filing?
The filing indicates it covers 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits', but the specific details are within the attached documents.
When was the earliest event reported in this filing?
The earliest event reported was on March 3, 2025.
What is the primary business of Apogee Therapeutics, Inc. according to the filing?
The filing categorizes Apogee Therapeutics, Inc. under 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)' with SIC code 2836.
Where are Apogee Therapeutics, Inc.'s principal executive offices located?
The principal executive offices are located at 221 Crescent Street, Building 17, Suite 102b, Waltham, MA, 02453.
What other types of information are included in this 8-K filing besides financial results?
The filing also includes 'Regulation FD Disclosure' and 'Financial Statements and Exhibits'.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 3, 2025 regarding Apogee Therapeutics, Inc. (APGE).